ReviewFrontiers in oncology2014

Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies.

Volker Schirrmacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.